IRIS Accounts Production v25.1.3.33 06678349 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh066783492023-03-31066783492024-03-31066783492023-04-012024-03-31066783492022-03-31066783492022-04-012023-03-31066783492023-03-3106678349ns15:EnglandWales2023-04-012024-03-3106678349ns14:PoundSterling2023-04-012024-03-3106678349ns10:Director12023-04-012024-03-3106678349ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3106678349ns10:SmallEntities2023-04-012024-03-3106678349ns10:AuditExemptWithAccountantsReport2023-04-012024-03-3106678349ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3106678349ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3106678349ns10:FullAccounts2023-04-012024-03-3106678349ns10:Director22023-04-012024-03-3106678349ns10:RegisteredOffice2023-04-012024-03-3106678349ns5:CurrentFinancialInstruments2024-03-3106678349ns5:CurrentFinancialInstruments2023-03-3106678349ns5:Non-currentFinancialInstruments2024-03-3106678349ns5:Non-currentFinancialInstruments2023-03-3106678349ns5:ShareCapital2024-03-3106678349ns5:ShareCapital2023-03-3106678349ns5:RetainedEarningsAccumulatedLosses2024-03-3106678349ns5:RetainedEarningsAccumulatedLosses2023-03-3106678349ns5:ComputerEquipment2023-04-012024-03-3106678349ns5:ComputerEquipment2023-03-3106678349ns5:ComputerEquipment2024-03-3106678349ns5:ComputerEquipment2023-03-3106678349ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3106678349ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3106678349ns5:Secured2024-03-3106678349ns5:Secured2023-03-31
















Medicase Limited

Financial Statements for the Year Ended 31 March 2024






Medicase Limited

Company Information
for the Year Ended 31 March 2024







DIRECTORS: J E Longstaffe
D P Hughes





REGISTERED OFFICE: Radnor House
Greenwood Close
Cardiff Gate Business Park
Cardiff
South Glamorgan
CF23 8AA





REGISTERED NUMBER: 06678349 (England and Wales)





ACCOUNTANTS: BPU Limited
Chartered Accountants
Radnor House
Greenwood Close
Cardiff Gate Business Park
Cardiff
CF23 8AA

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Medicase Limited


The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Medicase Limited for the year ended 31 March 2024 which comprise the Profit and loss, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at icaew.com/membershandbook.

This report is made solely to the Board of Directors of Medicase Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Medicase Limited and state those matters that we have agreed to state to the Board of Directors of Medicase Limited, as a body, in this report in accordance with icaew/compilation. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Medicase Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Medicase Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Medicase Limited. You consider that Medicase Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Medicase Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






BPU Limited
Chartered Accountants


28 May 2025

Medicase Limited (Registered number: 06678349)

Balance Sheet
31 March 2024

2024 2023
Notes £ £
CURRENT ASSETS
Debtors 4 636,559 752,574
Cash at bank and in hand 28,014 57,303
664,573 809,877
CREDITORS
Amounts falling due within one year 5 557,068 801,387
NET CURRENT ASSETS 107,505 8,490
TOTAL ASSETS LESS CURRENT
LIABILITIES

107,505

8,490

CREDITORS
Amounts falling due after more than
one year

6

12,231

22,435
NET ASSETS/(LIABILITIES) 95,274 (13,945 )

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 95,174 (14,045 )
SHAREHOLDERS' FUNDS 95,274 (13,945 )

Medicase Limited (Registered number: 06678349)

Balance Sheet - continued
31 March 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 May 2025 and were signed on its behalf by:





J E Longstaffe - Director


Medicase Limited (Registered number: 06678349)

Notes to the Financial Statements
for the Year Ended 31 March 2024


1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the net invoiced services, excluding value added tax from the ordinary activity of medical legal reporting.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% straight line

Pension costs
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

3. TANGIBLE FIXED ASSETS
Computer
equipment
£
COST
At 1 April 2023
and 31 March 2024 1,918
DEPRECIATION
At 1 April 2023
and 31 March 2024 1,918
NET BOOK VALUE
At 31 March 2024 -
At 31 March 2023 -

Medicase Limited (Registered number: 06678349)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024


4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Trade debtors 616,235 695,454
Other debtors & prepayments 20,324 57,120
636,559 752,574

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Bank loans and overdrafts 10,207 9,952
Trade creditors 385,623 578,885
Taxes & social security costs 104,020 145,855
Other creditors & accruals 57,218 66,695
557,068 801,387

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
2024 2023
£ £
Bank loans 12,231 22,435

7. SECURED DEBTS

The following secured debts are included within creditors:

2024 2023
£ £
Bank loans 22,438 32,387

The bank loan is secured by a fixed and floating charge over the assets of the company.